ArticleInternational journal of surgery (London, England)2022

Real-world treatment and survival outcome of malignant giant cell tumor of bone in the pre-denosumab versus post-denosumab era.

Xianglin Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.